• Profile
Close

Impact of respiratory virus molecular testing on antibiotic utilization in community-acquired pneumonia

American Journal of Infection Control Sep 13, 2017

Blatt SP, et al. - In this study, the clinical characteristics and antibiotic therapy of community-acquired pneumonia patients who were positive on a respiratory virus molecular test (polymerase chain reaction) with those who were negative were compared. Findings suggested a minimal impact of respiratory virus molecular polymerase chain reaction testing on reducing antibiotic utilization among viral pneumonia patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay